Rheumazentrum Ruhrgebiet

Running trials

• Not yet recruiting

  Impact Of Upadacitinib On The Frequency Of Acute Recurrent Anterior Uveitis In Patients With Axial Spondyloarthritis

  NCT07018206· Phase 4· Source

• Recruiting

  A Study to Assess the Efficacy and Safety of RO7790121 in Participants With Moderate to Severe Rheumatoid Arthritis Who Have Not Responded to or Who Cannot Tolerate Tumor Necrosis Factor (TNF) and/or Janus Kinase (JAK Inhibitors)

  NCT07137598· Phase 2· Source

• Recruiting

  EAST-1 (ERAP-inhibition in Axial Spondyloarthritis Trial - 1)

  NCT07047703· Phase 1/2· Source

• Active, not recruiting

  A Study of CC-97540 (BMS-986353 or Zola-cel), CD19-Targeted NEX-T CAR T Cells, in Participants With Active SLE Despite Immunosuppressants (Breakfree-SLE)

  NCT07015983· Phase 2· Source

• Recruiting

  A Comparison Study of Persistence of UPadacitinib vs. TNF-inhibitoRs In a German Real-world SettING

  NCT06712628· Source

• Active, not recruiting

  Avacostar - (PASS)

  NCT05897684· Source

• Active, not recruiting

  A Study Evaluating the Effect of Filgotinib in Participants With Active Axial Spondyloarthritis

  NCT05785611· Phase 3· Source

• Active, not recruiting

  A Study to Assess Disease Activity in Adult Participants With Axial Spondyloarthritis Who Receive Upadacitinib in a Real-world Setting

  NCT05094128· Source

• Active, not recruiting

  A Study of Guselkumab and Interleukin-17 (IL-17) Inhibitor Therapies in Participants With Psoriatic Arthritis in Routine Clinical Practice

  NCT05049798· Source

• Active, not recruiting

  Prospective Observational Study of Filgotinib in Subjects With Rheumatoid Arthritis

  NCT04871919· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Ankylosing spondylitis2 recruiting
• Rheumatoid arthritis2 recruiting

Researchers

No researcher is linked here yet.

Closed trials

• Completed

  An Observational Study to Assess Change in Disease Activity and Treatment Patterns of Upadacitinib When Given Alone or Co-Administered With Methotrexate in Adult Participants With Active Psoriatic Arthritis

  NCT05616871· Source

• Completed

  Capability of Tofacitinib or Etanercept to Accelerate Tapering of NSAID and Treat-to-target Guided De-escalation of Corticosteroids in RA Patients

  NCT04485325· Phase 4· Source

• Completed

  A Study Comparing Upadacitinib (ABT-494) to Placebo and to Adalimumab in Participants With Psoriatic Arthritis Who Have an Inadequate Response to at Least One Non-Biologic Disease Modifying Anti-Rheumatic Drug (DMARD)

  NCT03104400· Phase 3· Source

Trial sites

• Rheumazentrum Ruhrgebiet, Ruhr-University Bochum1 trial
• Katholische Kliniken Rhein-Ruhr, St. Elisabeth Gruppe GmbH, Rheumazentrum Ruhrgebiet1 trial
• Rheumazentrum Ruhrgebiet7 trials
• Rheumazentrum Ruhrgebiet /ID# 1456200 trials
• Rheumazentrum Ruhrgebiet /ID# 1639301 trial
• Rheumazentrum Ruhrgebiet /ID# 2072120 trials
• Rheumazentrum Ruhrgebiet /ID# 2072160 trials
• Rheumazentrum Ruhrgebiet /ID# 2404601 trial
• Rheumazentrum Ruhrgebiet /ID# 2526700 trials
• Rheumazentrum Ruhrgebiet /ID# 2529391 trial
• Rheumazentrum Ruhrgebiet /ID# 2755181 trial
• Rheumazentrum Ruhrgebiet (Site 0600)0 trials
• Rheumazentrum Ruhrgebiet (Site 6400)0 trials

Conditions

Diseases this institution publishes on or runs trials for.

• Ankylosing spondylitis52 works · 4 trials
• Psoriatic arthritis36 works · 3 trials
• ANCA-associated vasculitis4 works · 1 trials